Literature DB >> 28961886

The Neuropsychology of Huntington's Disease.

Julie S Snowden1,2.   

Abstract

Huntington's disease is an inherited, degenerative brain disease, characterized by involuntary movements, cognitive disorder and neuropsychiatric change. Men and women are affected equally. Symptoms emerge at around 40 years, although there is wide variation. A rare juvenile form has onset in childhood or adolescence. The evolution of disease is insidious and structural and functional brain changes may be present more than a decade before symptoms and signs become manifest. The earliest site of pathology is the striatum and neuroimaging measures of striatal change correlate with neurological and cognitive markers of disease. Chorea and other aspects of the movement disorder are the most visible aspect of the disease. However, non-motor features have greatest affect on functional independence and quality of life, so require recognition and management. The evidence-base for non-pharmacological treatments in Huntington's disease is currently limited, but recent intervention studies are encouraging.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Basal ganglia; Congenital/genetic Disorders; Executive functions; Huntington's disease; Movement disorders; Subcortex

Mesh:

Year:  2017        PMID: 28961886     DOI: 10.1093/arclin/acx086

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  19 in total

1.  Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.

Authors:  Sandra M Holley; Laurie Galvan; Talia Kamdjou; Carlos Cepeda; Michael S Levine
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 2.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

3.  deutetrabenazine for the treatment of chorea associated with Huntington's disease.

Authors:  Harshit Gupta; Wil Perkins; Cain Stark; Sathya Kikkeri; Juyeon Kakazu; Adam Kaye; Alan Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

4.  Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington's Disease.

Authors:  S M Holley; K D Oikonomou; C M Swift; L Mohan; B Matthews; O Vega; G Mkrtchyan; C Cepeda; M S Levine
Journal:  eNeuro       Date:  2022-06-22

5.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 6.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

7.  Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Shujun Chen; Tianyu Liang; Tao Xue; Shouru Xue; Qun Xue
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

8.  Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task.

Authors:  Thomas Hunefeldt; Sabrina Maffi; Simone Migliore; Ferdinando Squitieri; Marta Olivetti Belardinelli
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

9.  Structural brain correlates of dementia in Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Neuroimage Clin       Date:  2020-09-09       Impact factor: 4.881

Review 10.  Juvenile Huntington's disease: two case reports and a review of the literature.

Authors:  Sigita Lesinskienė; Darja Rojaka; Rūta Praninskienė; Aušra Morkūnienė; Aušra Matulevičienė; Algirdas Utkus
Journal:  J Med Case Rep       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.